These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31523030)

  • 1. Multi-omic approaches to improve outcome for T-cell acute lymphoblastic leukemia patients.
    van der Zwet JCG; Cordo' V; Canté-Barrett K; Meijerink JPP
    Adv Biol Regul; 2019 Dec; 74():100647. PubMed ID: 31523030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
    Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
    PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.
    Kunz JB; Rausch T; Bandapalli OR; Eilers J; Pechanska P; Schuessele S; Assenov Y; Stütz AM; Kirschner-Schwabe R; Hof J; Eckert C; von Stackelberg A; Schrappe M; Stanulla M; Koehler R; Avigad S; Elitzur S; Handgretinger R; Benes V; Weischenfeldt J; Korbel JO; Muckenthaler MU; Kulozik AE
    Haematologica; 2015 Nov; 100(11):1442-50. PubMed ID: 26294725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers in ALL: Clinical implications.
    Kimura S; Mullighan CG
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101193. PubMed ID: 33038982
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Bond J; Touzart A; Leprêtre S; Graux C; Bargetzi M; Lhermitte L; Hypolite G; Leguay T; Hicheri Y; Guillerm G; Bilger K; Lhéritier V; Hunault M; Huguet F; Chalandon Y; Ifrah N; Macintyre E; Dombret H; Asnafi V; Boissel N
    Haematologica; 2019 Aug; 104(8):1617-1625. PubMed ID: 30655366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia.
    Paganelli F; Lonetti A; Anselmi L; Martelli AM; Evangelisti C; Chiarini F
    Adv Biol Regul; 2019 Dec; 74():100649. PubMed ID: 31523031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biological insights in T-cell acute lymphoblastic leukemia.
    Durinck K; Goossens S; Peirs S; Wallaert A; Van Loocke W; Matthijssens F; Pieters T; Milani G; Lammens T; Rondou P; Van Roy N; De Moerloose B; Benoit Y; Haigh J; Speleman F; Poppe B; Van Vlierberghe P
    Exp Hematol; 2015 Aug; 43(8):625-39. PubMed ID: 26123366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational spectrum of adult T-ALL.
    Neumann M; Vosberg S; Schlee C; Heesch S; Schwartz S; Gökbuget N; Hoelzer D; Graf A; Krebs S; Bartram I; Blum H; Brüggemann M; Hecht J; Bohlander SK; Greif PA; Baldus CD
    Oncotarget; 2015 Feb; 6(5):2754-66. PubMed ID: 25595890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics and pharmacogenomics of pediatric acute lymphoblastic leukemia.
    Wu C; Li W
    Crit Rev Oncol Hematol; 2018 Jun; 126():100-111. PubMed ID: 29759551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
    Bond J; Graux C; Lhermitte L; Lara D; Cluzeau T; Leguay T; Cieslak A; Trinquand A; Pastoret C; Belhocine M; Spicuglia S; Lheritier V; Leprêtre S; Thomas X; Huguet F; Ifrah N; Dombret H; Macintyre E; Boissel N; Asnafi V
    J Clin Oncol; 2017 Aug; 35(23):2683-2691. PubMed ID: 28605290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.
    Hefazi M; Litzow MR
    Curr Hematol Malig Rep; 2018 Aug; 13(4):265-274. PubMed ID: 29948644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics.
    Kumar A; Drusbosky LM; Meacham A; Turcotte M; Bhargav P; Vasista S; Usmani S; Pampana A; Basu K; Tyagi A; Lala D; Rajagopalan S; Birajdar SC; Alam A; Ghosh Roy K; Abbasi T; Vali S; Sengar M; Chinnaswamy G; Shah BD; Cogle CR
    Leuk Res; 2019 Mar; 78():3-11. PubMed ID: 30641417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset.
    Padi SKR; Luevano LA; An N; Pandey R; Singh N; Song JH; Aster JC; Yu XZ; Mehrotra S; Kraft AS
    Oncotarget; 2017 May; 8(18):30199-30216. PubMed ID: 28415816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia.
    Gębarowska K; Mroczek A; Kowalczyk JR; Lejman M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood and adolescent lymphoid and myeloid leukemia.
    Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM
    Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare Drivers at Low Prevalence with High Cancer Effects in T-Cell and B-Cell Pediatric Acute Lymphoblastic Leukemia.
    Mandell JD; Diviti S; Xu M; Townsend JP
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.